AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit

Tzu-Yin Lin, Joelle Fenger, Sridhar Murahari, Misty D. Bear, Samuel K. Kulp, Dasheng Wang, Ching Shih Chen, William C. Kisseberth, Cheryl A. London

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint Dive into the research topics of 'AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds